FDA faulted for failure to track safety issues with drugs already on market -

January 14, 2016, Stat. Most Americans assume that drugs approved by the Food and Drug Administration are safe to take as directed. But safety concerns often arise only after the drugs go on the market, when companies or doctors tell the FDA about cases of patients who have fallen ill or died from their medications.

Politicians want to speed up drug approvals. That could backfire. -

November 24, 2015 To patients grappling with incurable diseases, new therapies can’t come quickly enough. But a pair of new studies found that speeding up this process could put Alzheimer’s, Parkinson’s, and depression drugs that are ineffective or harmful on the market..

The 21st Century Cures Act could be a harmful step backward -

November 19, 2015. The Washington Post. Precision medicine is the next big thing in health care, and it’s also one of the few health goals that Congress and the White House agree on. But while we await treatments targeting the precise genetic makeups of individuals and diseases, medical researchers still are not paying enough attention to the most important kinds of differences among patients: those of sex, age and race.

Senate counterpart to 21st Century Cures bill is struggling -

October 25, 2015. Politico. The Senate’s companion effort to the House-passed 21st Century Cures is struggling to navigate a dramatically different political reality than the one that helped rocket the medical innovation bill through the lower chamber over the summer.